Actuate Therapeutics

1401 Foch Street
Suite 140
Fort Worth
United States


Show jobs for this employer

About Actuate Therapeutics

Actuate Therapeutics is a private biopharmaceutical company focused on the development of compounds for use in the treatment of cancer, and inflammatory diseases leading to fibrosis and neurodegeneration.
Actuate was founded in 2015 with a mission of discovering, developing, and commercializing new agents that target GSK-3ß, based on intellectual capital developed in the laboratories of the University of Illinois-Chicago and Northwestern University. The company is led by a senior management and scientific team with decades of pharmaceutical industry experience leading successful discovery, development, and commercialization of new therapeutic agents and health related technologies.
President & CEO: Daniel M. Schmitt
CMO: Francis J. Giles, MB, MD, FRCPI, FRCPath
Co-Founder & Chief Scientific Advisor: Andrew P. Mazar, Ph.D.
Consulting Scientific Director: Andrey Ugolkov (Ougolkov), M.D., Ph.D.
Please click here for Actuate Therapeutics' research.

16 articles with Actuate Therapeutics